These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29288595)

  • 21. The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.
    Backx M; Lewszuk A; White JR; Cole J; Sreedharan A; van Sanden S; Diels J; Lawson A; Neal KR; Wiselka MJ; Ito T; Irving WL
    J Viral Hepat; 2014 Mar; 21(3):208-15. PubMed ID: 24438682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.
    Nguyen GC; Segev DL; Thuluvath PJ
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1092-9. PubMed ID: 17625983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.
    Adejumo AC; Adegbala OM; Adejumo KL; Bukong TN
    Can J Gastroenterol Hepatol; 2018; 2018():9430953. PubMed ID: 30345261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.
    Wang H; Swann R; Thomas E; Innes HA; Valerio H; Hayes PC; Allen S; Barclay ST; Wilks D; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Gunson R; Mclntyre PG; Hunt A; Hutchinson SJ; Mills PR; Dillon JF
    J Viral Hepat; 2018 Aug; 25(8):930-938. PubMed ID: 29577515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of TT virus infection in patients with chronic hepatitis C.
    Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
    Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimates on HCV disease burden worldwide - filling the gaps.
    Wedemeyer H; Dore GJ; Ward JW
    J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hepatitis C in the Czech Republic: Forecasting the disease burden.
    Fraňková S; Urbánek P; Husa P; Němeček V; Razavi H; Razavi-Shearer D; Chlíbek R; Šperl J
    Cent Eur J Public Health; 2019 Jun; 27(2):93-98. PubMed ID: 31241282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.
    Bruden DJT; McMahon BJ; Townshend-Bulson L; Gounder P; Gove J; Plotnik J; Homan C; Hewitt A; Barbour Y; Spradling PR; Simons BC; McArdle S; Bruce M
    Hepatology; 2017 Jul; 66(1):37-45. PubMed ID: 28195349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness.
    Innes HA; Hutchinson SJ; Barclay S; Cadzow E; Dillon JF; Fraser A; Goldberg DJ; Mills PR; McDonald SA; Morris J; Stanley A; Hayes P;
    Hepatology; 2013 Feb; 57(2):451-60. PubMed ID: 22961861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030.
    Schaefer B; Viveiros A; Al-Zoairy R; Blach S; Brandon S; Razavi H; Dorn L; Finkenstedt A; Effenberger M; Graziadei I; Sarcletti M; Tilg H; Zoller H
    PLoS One; 2018; 13(7):e0200750. PubMed ID: 30001427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
    Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
    J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Barritt AS; Jiang Y; Schmidt M; Hayashi PH; Bataller R
    Dig Dis Sci; 2019 Jun; 64(6):1460-1469. PubMed ID: 30673984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.
    Saeed MJ; Olsen MA; Powderly WG; Presti RM
    J Clin Gastroenterol; 2017 Jan; 51(1):70-76. PubMed ID: 27306942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec.
    Kamstra R; Azoulay L; Steele R; Klein MB; Greenaway C
    Clin Infect Dis; 2016 Dec; 63(11):1439-1448. PubMed ID: 27501843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
    Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
    J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
    Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
    J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Abergel A; Rotily M; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):340-348. PubMed ID: 26546175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.